The dispute centers on a 383-acre site once used for diaper manufacturing that neighbors say threatens wetlands and wildlife ...

Johnson & Johnson remains a buy as business momentum accelerates, with Q4 revenue up 9.1% YoY and strong U.S. sales ...

As Johnson & Johnson seeks city incentives to help expand its Jacksonville-based vision products subsidiary, company officials are touting the growth potential of the unit.

Johnson & Johnson (JNJ) is expected to announce a 21% jump in its fourth quarter earnings on January 21, before the bell.

Johnson & Johnson received approval from the Food and Drug Administration for a treatment for certain patients with multiple myeloma, an incurable form of blood cancer.

A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...

Morgan Stanley believes that Johnson and Johnson has stronger earnings potential driven by its robust product cycle. The bank ...

Johnson & Johnson is set to report its Q4 results on Wednesday, facing one of the most important transitions in its modern ...

A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made by Johnson & Johnson caused their ovarian cancer. The giant health care company said it would appeal ...

By Jonathan Stempel Jan 12 (Reuters) - Johnson & Johnson convinced Delaware's highest court to throw out part of a $1 billion damages award for breaching its 2019 agreement to buy Auris Health, a ...

A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...

A California jury on Friday awarded $40 million to two women who said Johnson & Johnson‘s baby powder was to blame for their ovarian cancer. Erik Haas, Johnson & Johnson‘s worldwide vice president of ...